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Abstract
The adult lung contains several distinct stem cells, although their properties and full potential are still being sorted out. We
previously showed that ectopic Sox2 expression in the developing lung manipulated the fate of differentiating cells. Here,
we addressed the question whether fully differentiated cells could be redirected towards another cell type. Therefore, we
used transgenic mice to express an inducible Sox2 construct in type II pneumocytes, which are situated in the distal,
respiratory areas of the lung. Within three days after the induction of the transgene, the type II cells start to proliferate and
form clusters of cuboidal cells. Prolonged Sox2 expression resulted in the reversal of the type II cell towards a more
embryonic, precursor-like cell, being positive for the stem cell markers Sca1 and Ssea1. Moreover, the cells started to co-
express Spc and Cc10, characteristics of bronchioalveolar stem cells. We demonstrated that Sox2 directly regulates the
expression of Sca1. Subsequently, these cells expressed Trp63, a marker for basal cells of the trachea. So, we show that the
expression of one transcription factor in fully differentiated, distal lung cells changes their fate towards proximal cells
through intermediate cell types. This may have implications for regenerative medicine, and repair of diseased and damaged
lungs.
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Introduction
The mammalian lung is a complex organ with a large and
highly vascularized epithelial surface area. The airway epithelium
is lined with a diversity of cell types that vary in abundance along
the proximal-distal axis. The conducting airways have a pseudo-
stratified epithelium to facilitate mucociliary transport, which
gradually transforms into a simple columnar and cuboidal
epithelium. Finally, the respiratory part of the lungs consists of
squamous epithelium for efficient gas exchange. Cellular homeo-
stasis is important for the maintenance of the lung, and in mature
lungs, cell turnover and proliferation is low [1]. However, after
bronchiolar injury, either infections or mechanical insults such as
artificial ventilation to the lung, the respiratory epithelium
extensively proliferate to regenerate and repair the injured lung,
indicating the presence of lung progenitor cells [2,3].
In general, lung stem/progenitor cells should have the capacity
to self-renew and differentiate into specialized cell lineages. In
mouse, endogenous adult progenitor/stem cells function to
repopulate the damaged lung epithelium [4–6]. Several distinct
populations of stem/progenitor cells have been described to be
present in the conducting and respiratory epithelium [2,6–10].
Lineage tracing studies in mice have shown that the proximal
airway basal cells act as stem cells, giving rise to Clara and ciliated
cells during lung injury [11,12]. On the other hand, recent data
suggest that Clara cells may differentiate into Trp63 positive basal
cells in damaged lung parenchyma and into alveolar type II cells
upon bleomycin treatment or influenza infection [2,13]. Other
putative proximal stem cells include a subpopulation of toxin-
resistant Clara cells that function as bronchiolar stem cells located
within two discrete cell niches: the neuroepithelial body (NEB) and
the bronchoalveolar duct junction (BADJ) [11,14,15]. Moreover,
several studies have shown the differentiation of type II cells into
type I cells [2,16]. Thus, intrinsic cell populations exist in the lung
that may be triggered to differentiate into distinct cell types.
Sox2 is among other transcription factors essential for lung
development and maturation [17–19]. Sox2 is a member of the
highly conserved HMG box family of transcription factors and
required early in embryonic development to maintain pluripoten-
cy and self-renewal in embryonic stem (ES) cells. In mice, Sox2 is
required for normal morphogenesis and homeostasis of diverse
tissues, including neural stem cells; retinal stem cells taste buds;
hair sensory follicles in the ear; and epithelia of trachea, lung, and
esophagus [17,20–22]. Sox2 is one of the original factors together
with Oct4, Klf4, and c-Myc required for the reprogramming of
somatic cells [23]. In the embryonic lung, Sox2 is expressed in the
developing respiratory epithelium [18], whereas in adult lungs,
expression of Sox2 is restricted in epithelial cells, in the adult
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trachea, airway/bronchiolar epithelium and the conducting
airways. [17,24,25]. Sox2 is completely absent from the respiratory
airways, where another member of the Sry-box family, Sox9, is
expressed. Thus, Sox2 and Sox9 show a reciprocal expression
pattern in the lung.
Many reports have described variations of the original cocktail
of factors to generate multipotent iPS cells in vitro (reviewed in
[26,27]). Lineage conversion or trans differentiation have recently
been reported in vitro and in vivo (review [28–31]. Mouse and
human fibroblasts and other types of cells have been trans-
differentiated directly into post-mitotic neurons with combinations
of transcription factors [32–37]. It was recently reported that the
combination of three or more factors can reprogram mouse
fibroblasts into induced neural stem cells (iNSCs) with self-
renewing ability [38–41].
Recently, we showed that ectopic expression of Sox2 during
lung development induced the differentiation of embryonic
epithelial cells into basal and neuroendocrine cells [18]. Since
subsets of epithelial cells in the developing lung may still be
multipotent, we wondered whether ectopic expression of Sox2
could change the faith of fully differentiated alveolar type II cells in
vivo. Therefore, we ectopically expressed Sox2 in alveolar type II
cells using a tet-inducible, bi-transgenic approach. We show that
conditional expression of Sox2 in the alveolar epithelium results in
emphysematous lungs concomitant with the emergence of
aberrant structures containing cuboidal cells in the periphery of
the lungs. Moreover, Sox2 was found to induce progenitor-like
cells which become proliferative and differentiate into cuboidal
and basal-like cells, implying that fully differentiated type II cells
can be reprogrammed with a single transcription factor to develop
into cells expressing proximal markers.
Materials and Methods
Mouse breeding and genotyping
Mice were kept under pathogen-free conditions and all
experiments described in this study were performed according to
the guidelines and with the written approval of the local ethics
committee, ‘‘Dier Ethische Commissie’’ (Animal Ethics Commis-
sion), permit number EMC 2206. Generation of the Sox2
transgenic mouse line has been described before [18]. Lung-
specific expression of the myc-Sox2 transgene was obtained by
breeding the myc-Sox2 line with the SPC-rtTA transgenic mice
(generous gift of Jeffrey Whitsett, Cincinnati), subsequently
referred to as iSox2SPC-rtTA. Doxycycline was administered in
the drinking water (2 mg/ml doxycycline, 5% sucrose), and lungs
were harvested after 1, 3, 6, 9, or 28 days. Transgenic mice were
genotyped by PCR of tail-tip DNA using transgene specific
primers as previously described. Each experiment was executed on
at least three independent lungs of iSox2SPC-rtTA, single transgenic
and wild type pups.
Immunohistochemistry and Immunofluorescence
Lungs of adult mice were inflated with 4% paraformaldehyde/
phosphate-buffered saline (PBS), subsequently fixed by immersion
overnight at 4uC, and processed according to standard protocols
for paraffin embedding. Immunohistochemistry (IHC) was per-
formed as previously described using primary antibodies for goat-
anti Sox2 (1:500 immune system), mouse anti myc (1:1000, Roche)
rabbit anti-phospho-histone H3 (1:1000; Millipore), rabbit anti-
CCSP (1:1000, 7-Hills), Mouse anti Ssea (1:200, Millipore), rabbit
anti-cyclin D1 (1:500; Abcam), rat anti-Sca-1 (1:500; Abcam),
rabbit anti-proSP-C (1:1000; Seven Hills), Mouse anti-Trp63
(1:200; Santa cruz), and Goat anti-CCSP (1:1,000; Seven Hills)
[42]. Briefly, sections (5 mm) were deparaffinised, rehydrated and
microwave treated for antigen retrieval in 10 mM citric acid
buffer, pH 6.0. Slides were incubated with primary antibodies
diluted in PBS/0,5% Triton/0.5% BSA overnight at 4uC,
followed by incubation with the appropriate secondary antibody
(1:100; Vector Labs) and amplification with ABC reagent
(Vectastain Elite ABC kit; Vector Labs). Antigen localization was
detected with nickel-diaminobenzidine. Sections were counter-
stained with haematoxylin and coverslipped using Permount
(Fisher Scientific). Quantification of IHC staining was performed
by counting positive cells in five separate microscopic fields with a
406objective of three independent experiments, after which a bar
graph was prepared using PRISM graphpad. Data are represented
as the average of the number of positive cells per field, including
the standard error of the mean (SEM).
Immunofluorescence was performed as described above, but
substituting the secondary antibodies with fluorophore labelled
antibodies (Alexa Fluor-350, Alexa Fluor-488, and Alexa Fluor-
594; Molecular Probes). Sections were mounted with Vectashield
anti-fade reagent containing DAPI (Vector Labs). Brightfield and
fluorescent images were obtained using a Zeiss Axioplan2
microscope equipped with AxioVision Software or a Leica SP5
confocal microscope.
Isolation and culturing of alveolar type II cells (AVTII)
Alveolar epithelial cells were isolated from the lungs of Sox2SPC-
rtTA mice by Dispase (BD, Pharmingen) digestion as described
previously with few modifications [43]. Lungs were exsanguinated
by perfusing through the right ventricle with 4 ml PBS after
opening the peritoneum, clipping the vena cava inferior and
removing the ribcage. 1 ml Dispase (BD, Pharmingen) was
instilled over a tracheal cannula into the lung, immediately a
sterilized suture (Braun) was used to tighten a node around the
cannulised trachea. Lungs were isolated, incubated for 45 minutes
in 1 ml Dispase at room temperature and transferred to a culture
dish containing 5 ml DMEM/F12 medium (Gibco) supplemented
with 0.04 mg/ml DNase I (AppliChem), 3.6 mg/ml D-(+)-Glucose
(AppliChem) and 1% Penicillin/Streptomycin (P/S). The small
airways were gently removed and the obtained cell suspension was
serially filtered through 100, 70 and 40 mm nylon meshes and
centrifuged at 200 g for 10 minutes at 15uC. The supernatant was
discarded and the cell pellet was resuspended in 500 ml DMEM/
F12 (Gibco) medium supplemented with 3.6 mg/ml D-(+)-Glucose
(AppliChem), 1% P/S and 2% FCS. AVTII cells were cultured in
DMEM/F10 containing 10% FCS and 1% P/S in tissue culture
cover slip immersed in 12 well plates (Corning, NY) previously
coated with collagen (Inamed); cultures were maintained in a 5%
CO2/air incubator.
Plasmids, Cell culture and Luciferase Reporter Assays
A 500 bp minimal promoter fragment immediately upstream of
the Sca1 transcriptional start site was PCR amplified from
genomic DNA using the primers Forward 59-TAAACGCGCA-
CACGTTTCTC-39 and Reverse 59-GGCCAGCATCT-
GACCTCTTT-39, and cloned into the pGL4 luciferase. Human
embryonic kidney HEK 293T cells maintained under standard
culture conditions were plated on 6-well plates (3.56105 cells per
well). 24 hours after plating, the HEK-293Tcells were transiently
transfected using Lipofectamine LTX (Invitrogen) with 2.5 mg of
the following Firefly luciferase reporter plasmids (pGL4-Sca-1
1 mg of Renilla luciferase plasmid (transfection control), and 2.5 mg
of empty vector (pcDNA3) or plasmids expressing full length Sox2
(WT-Sox2), or one of the mutant Sox2 (DTAD and DHMG)[44].
After 24 hr, cells were harvested and luciferase activity was
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measured using the Dual-Luciferase Reporter Assay system
(Promega). The lysate was assayed for luciferase and Renilla
activity using the GloMax 96 Microplate Luminometer with Dual
Injectors (Promega, Madison, WI), according to the Dual-
Luciferase Reporter Assay system kit protocol (Promega). The
luciferase activity was calculated relative to the TK Renila. All
reporter assays were performed in triplicate, and the bars in the
figures denote the standard error of the mean (SEM).
Chromatin Immunoprecipitation
Human lung adenocarcinoma epithelial A549 cells were
cultured in hypoxic conditions and the ChIP assays were
performed essentially as described previously using 66107 cells
[45–47]. The immunoprecipitated DNA was analysed with
specific primers in a Q-PCR assay to assess the enrichment of
the promoter regions of the Amylase (Amy), Sca1 and Gli2 genes.
The amount of immunoprecipitated DNA with SOX2 and control
IgG was calculated based on threshold cycle [C(t)] using the DC(t)
method and normalized to input samples. Results are expressed as
fold enrichment of SOX2 immunoprecipitated samples relative to
IgG controls, and represent the average of three replicates of two
independent experiments including the SEM. PCR primers are
listed in Table 1.
Results
Expression of Sox2 in alveolar type II cells results in
morphological changes
Ectopic expression of iSox2 in relative uncommitted, naı¨ve
epithelial cells during development resulted in their differentiation
into proximal epithelial cells, primarily basal cells [18,46]. We
wondered whether induced expression of iSox2 in fully differen-
tiated cells would affect the cells in an autonomous manner.
Therefore, we expressed the iSox2 transgene in adult lungs using
the SPC-rtTA transgene, which was reported to be expressed in a
subset of type II cells in adult lungs [48]. The immediate effect of
the expression of the transgene was evaluated after one, three, six,
and nine days of doxycycline induction, as well as prolonged
expression for four weeks. The mice did not show typical lung-
related phenotypic abnormalities, such as breathing problems, and
were indistinguishable from control mice. However, histological
analysis of HE stained sections revealed significant structural
abnormalities after treatment with doxycycline for four weeks in
the lungs of the Sox2SPC-rtTA mice, which resembled an
emphysematous-like appearance (Figure 1B, stars). The air spaces
in the lungs of iSox2SPC-rtTA mice were significantly enlarged and
accompanied by the destruction of the normal alveolar architec-
ture compared to control mice (Figure 1A–C). The disrupted areas
were interspersed within relative normal alveolar regions, indicat-
ing that the phenotype was not uniform throughout the lung of
iSox2SPC-rtTA mice. The normal appearance of lung architecture
in some regions was an indication of incomplete penetrance of the
transgene (Figure 1B arrow). There was no evidence of inflam-
matory cells in the alveolar parenchyma and airway spaces, nor
were any fibrotic changes observed. Careful analysis of the lungs
exposed to doxycycline showed the emergence of clusters of
cuboidal cells already after three days of doxycycline treatment
(Figure 1C, arrows). Next, we analyzed the extend of the transgene
expression after the specified time points by immunohistochem-
istry with an antibody against the myc epitope (Myc), which is
present at the N-terminus of the iSox2 transgenic protein. In
contrast to lungs of wild type control or non-induced transgenic
mice (Figure 1D), clear positive cells were already detected after
one day of doxycycline exposure in subsets of type II cells in the
lungs of the iSox2SPC-rtTA mice (Figure 1E), which progressively
increased with prolonged exposure to doxycycline for 3, 6, 9 and
28 days (Figure 1F–I). Moreover, the iSox2 expressing cells were
positive for the type II cell marker Prospc, indicating that indeed
the transgene was expressed in type II cells (Figure 1J–L, arrows
indicate positive clusters; Figure S1). Although the appearance of
positive cells after one day did not change the overall structure of
the lung, the gradual increase of Sox2 positive cells caused cellular
changes, from typical type II cells to cuboidal shaped cells. The
appearance of these clusters of cuboidal cells suggested that the
transgenic iSox2 induced cellular changes in the type II cells.
Therefore, we analyzed the expression of the type II cell
differentiation marker lysophosphatidylcholine acyltransferase 1,
Lpcat1, which is involved in the production of the main
phospholipid of surfactant, dipalmitoylphosphatidylcholine. Lungs
of iSox2SPC-rtTA were analyzed after the induction of the transgene
with dual immunofluorescence staining (Figure 2). Colocalization
of Lpcat and iSox2 was observed after one (Figure 2A) and six
(Figure 2B) days of doxycycline, but vanished after longer
exposure with doxycycline (Figure 2C), indicating that these cells
lost the differentiated type II cell characteristics. Thus, expression
of iSox2 in peripheral respiratory epithelial cells expanded with
the duration of doxycycline administration and induced the
appearance of clusters of cuboidal shaped cells, leading to
disorganized alveolar septa and loss of the normal lung architec-
ture.
Sox2 induces proliferation in alveolar type II cells in vivo
Although cell turnover and proliferation is low during
homeostasis in mature lungs, we and others previously showed
Table 1. Primers used for ChIP-qPCR.
Gene orientation sequence
SOX2 forward 59 - CATGCACCGCTACGACG - 39
reverse 59 - CGGACTTGACCACCGAAC - 39
GLI2 forward 59 - TAGAATTGCTCCTGCACTTC - 39
reverse 59 - ATGTCGGATGACCCTTTCTC - 39
AMY forward 59 - GGGAAAAGGCAGCATATTG - 39
reverse 59 - CACGCTAAATTGCCTGTGAA - 39
SCA1 forward 59 - ATGCCTTTATAGCCCCTCT - 39
reverse 59 - GTCATGAGCAGCAATCCACA - 39
doi:10.1371/journal.pone.0107248.t001
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that Sox2 induced proliferation in lung epithelium [18,19,46].
Since Sox2 induced the appearance of an increasing number of
cell clusters within the alveolar epithelium, we analyzed whether
Sox2 induced proliferation in fully differentiated alveolar type II
cells using an antibody against the mitotic cell marker phospho-
histone H3 (Phh3). Contrasting the non-proliferative, homeostatic
lungs derived from control lungs, Phh3 positive cells were observed
in the cuboidal clusters of the lungs of iSox2SPC-rtTA exposed to
doxycycline (Figure 3A versus 3B–D). The number of proliferative
cells gradually increased with the duration of transgene expression
in iSox2SPC-rtTA, starting to become apparent after six days of
induction (Figure 3E). Dual immunofluorescence staining revealed
co-localization of Phh3 and iSox2 in the induced clusters of
alveolar cells, confirming that proliferation occurred within the
transgene-expressing cells (Figure 3F; Figure S2). So, iSox2
induced type II cells to proliferate and induced cellular changes,
ultimately leading to abnormal lung architecture.
Figure 1. Ectopic Sox2 expression induces abnormal cell clusters. Representative HE staining of a control lung (A) demonstrating the normal
lung architecture and of iSox2SPC-rtTA lungs after 4 weeks doxycycline treatment (B) showing numerous, enlarged emphysematous structures
(asterisks) with cuboidal cell clusters (C). Representative IHC staining for the myc-epitope in wild type control (D) and iSox2SPC-rtTA lungs (E–I) after 1,
3, 6, 9 and 28 days of doxycycline treatment. Transgenic iSox2 positive myc staining is already evident after 1day of dox administration (E), which
gradually increased in time (F–I). The positive cells are clearly forming cuboidal clusters (arrows in I). Dual immunofluorescence staining shows the
colocalization of the transgenic Sox2 (iSox2, red) with the type II cell marker Prospc (green) after 6 days (J), 9 days (K) and 28 days (L) of doxycycline
treatment. Scale bars 200 mm (A, B), 100 mm (C), 50 mm (D–I) and 25 mm (J–L).
doi:10.1371/journal.pone.0107248.g001
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Figure 2. Sox2 induces a gradual loss of differentiated type II cells. Dual immunofluorescence staining of lungs treated with doxycycline for
1 (A), 6 (B) and 9 (C) days shows a gradual loss of colocalization of the type II cell differentiation marker Lpcat1 (green) and the transgenic Sox2 (iSox2,
red), indicating that Sox2 induces cellular changes in the type II cells. Scale bar: 25 mm.
doi:10.1371/journal.pone.0107248.g002
Figure 3. Sox2 induces proliferation in terminally differentiated alveolar type II pneumocytes. Lungs of control (A) and iSox2SPC-rtTA mice
treated with doxycycline for 6 (B), 9 (C) or 28 (D) days were analyzed with an antibody against the mitotic cell marker Phh3. Representative images
show proliferation in individual type II cells after 6 days of iSox2 induction (B), which gradually develop into proliferative clusters of cells (C, D). (E)
Quantification of Phh3 staining indicates the correlation between the increase of Phh3 positive cells and time of doxycycline expression. (F)
Colocalization of iSox2 and Phh3 is shown by dual immunofluorescence labeling after 28 days of doxycycline exposure (areas arrows indicate double
positive cells). Scale bars: 200 mm (A), 100 mm (B, C, D) and 25 mm (F).
doi:10.1371/journal.pone.0107248.g003
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iSox2 induces expression of Clara-like and basal-like cells
in AVTII cells
Since iSox2 induced the emergence of proximal cell types when
expressed during lung development [18,46], we analyzed if the
expression of iSox2 in terminal differentiated type II cells also
induced genes specific for proximal airway cells differentiation.
Therefore, the expression of Cc10 and Trp63, two markers of the
proximal Clara cells and basal cells, respectively, was analyzed.
Although Cc10 positive cells were present in the proximal
epithelium of the control lungs, the alveolar regions were
completely devoid of them (Figure 4A, C, E). In contrast, Cc10
positive cells were readily detected in the alveolar regions in the
lungs of the iSox2SPC-rtTA mice, even after one day of doxycycline
induction, and increased with prolonged exposure (Figure 4B, D,
F). Interestingly, these CC10 positive cells also expressed the type
II cell marker Spc, indicating that the iSox2 transgene induced the
emergence of a transient, bronchioalveolar stem cell (BASC)-like
population (CC10+/Spc+; arrows in Figure 4G–I; arrowheads
indicate CC10 negative cells). The BASC population has been
described to serve as a progenitor like population which is induced
upon damage to repopulate the airway epithelium [49,50].
Ectopic Sox2 expression induces progenitors-like cells
Since we observed the emergence of proximal markers in the
distal type II cells and the appearance of Spc+/CC10+ double
positive BASC-like cells, we wondered whether the differentiation
of proximal Clara and basal cells occurred through intermediate,
progenitor-like cells. Therefore, we analyzed the lungs of control
and iSox2SPC-rtTA mice, isolated at different time points after
doxycycline treatment, for the expression of Sca1 and Ssea1, two
markers normally expressed in progenitor cells [51,52]. Sca1and
Ssea1 were readily detected in the alveolar epithelium in iSox2SPC-
rtTA after 3 days of doxycycline exposure to these mice (Figure 5B,
F). This pattern of expression progressively increased after 9 days
of transgene induction (Figure 5C, G), and after four weeks of
doxycycline induction virtually all clusters of cells expressed Sca1
and Ssea1 (Figure 5D, H). Sca1 and myc-epitope double
immunofluorescence staining on lungs of iSox2SPC-rtTA animals
exposed for four weeks to doxycycline clearly showed co-
localization of Sca1 with the transgenic protein (Figure 5I–K).
Moreover, the previously identified Spc+/CC10+ cells also
appeared to express Sca1. In addition, Sca1 also co-expressed
with the basal cell marker Trp63 after four weeks of iSox2
induction, suggesting that the Sca-1+ cells gradually differentiate
into more committed cells (Figure 6A–D; Figure S3). Moreover,
the Trp63 positive cells represent the ectopic appearance of basal-
like cells in the distal epithelium of the iSox2SPC-rtTA lungs. Thus,
Sca1 was specifically induced in the subset of AVTII cells that
expressed transgenic iSox2, which indicates that iSox2 is able to
induce progenitor-like cells in terminally differentiated type II
cells.
Sox2 activates promoter-Luciferase construct for Sca-1
Next, we wondered whether Sca1 expression is directly
regulated by Sox2. Therefore, the Sca1 gene was analyzed for
putative Sox2 binding sites and within a region of 500 bp
immediately upstream of the transcriptional start site, a well-
conserved Sox2 binding motif was found. The functionality of this
potential Sox2 site was tested in vitro using a luciferase reporter
assay. The full length Sox2 protein (WT) induced the transcrip-
tional activity of the Sca1-luciferase construct sevenfold as
compared to baseline expression, whereas mutant Sox2 proteins
Figure 4. Sox2 induces Clara-like cells and BASC cells. Lungs of control (A, C, E) and iSox2SPC-rtTA (B, D, F) lungs treated with doxycycline for 3
(A, B), 9 (C, D) and 28 (E, F) days were stained with the Clara cell marker Cc10. Endogenous expression of Cc10 is demonstrated in the conducting
airways (A, arrowhead), which also shows the absence of Cc10 positive cells in the distal airways (A, C, E) of control lungs. The progressive increase in
number of Clara-like cells (Cc10+) in the iSox2SPC-rtTA lungs with prolonged induction of iSox2 is clearly noticeable (B, D, F). Colocalization of Cc10 (red)
and Prospc (green) is demonstrated with dual immunofluorescence staining (G–I), indicating the emergence of BASC cells (arrows). Arrowheads show
Prospc positive cells that lack CC10 (and iSox2) expression. Scale bars: 50 mm (B, D, F), 25 mm (G–I).
doi:10.1371/journal.pone.0107248.g004
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Figure 5. iSox2 induces the appearance of stem cell markers. Immunohistochemistry for Sca1 (A–D) and Ssea1 (E–H) was performed on lungs
of controls (A, E), and of iSox2SPC-rtTA mice after 3 (B, F), 9 (C, G) and 28 (D, H) days of doxycycline exposure. Sca1 and Ssea1 expressing cells are
completely absent in control lungs (A, E), but readily detectable after 3 days of exposure and progressively increased with duration of transgene
activation. Sca1 is clearly associated with iSox2+ cells, as shown by dual immunofluorescence staining (I–K). Scale bar 100 mm (D, H), 50 mm (K).
doi:10.1371/journal.pone.0107248.g005
Figure 6. Sox2 induces Sca1 positive cells by directly transactivating the Sca-1 gene. Triple immunofluorescence staining with Myc (iSox2,
blue), Sca1 (green) and Trp63 (red) on lungs of iSox2SPC-rtTA animals treated for 28 days with doxycycline demonstrate the emergence of Sca1/Trp63
positive cells (dotted areas; A–D). (E) Luciferase assay shows in vitro transactivation of the Sca1 minimal promoter by the full length Sox2 (WT), but
not by deletion constructs lacking the transactivation domain (DTAD) or the HMG domain (DHMG). The graph represents the average of three
independent experiments, and the bars denote the standard error of the mean (SEM). (F) SOX2 specific ChIP analysis showing specific enrichment of
the Sca1 promoter region used in the luciferase assay. The SEM is indicated of two independent experiments. (G) Quantification of the expression of
the different lung markers in vivo after the indicated time of doxycycline exposure. The graph shows the average of the number of positive cells of
five microscopic fields with a 406 objective of three independent experiments, including the corresponding SEM. Scale bar: 25 mm (D).
doi:10.1371/journal.pone.0107248.g006
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lacking either the transactivation domain (DTAD) or the HMG
domain (DHMG) did not transactivate the minimal Sca1 promoter
(Figure 6E). Next, the in vivo binding of SOX2 to this putative
Sox2 binding site was analyzed by chromatin immunoprecipita-
tion (ChIP), which revealed that SOX2 directly bound to this Sox2
motif of the SCA1 gene in the human bronchiolar cell line A549
(Figure 6F). These results demonstrated the direct binding and
activation of the Sca1 promoter by Sox2, and thus highlights a
novel transcriptional target gene of Sox2.
Transgenic Sox2 induces proximal markers in primary
AVTII cells
Quantification of the appearance of the different markers and
cell types in relation to the timing of doxycycline exposure,
suggested that Sox2 first initiates the appearance of markers
associated with progenitor-like cells (Figure 6G; Sca1+). In time,
differentiation markers emerge, as evidenced by the number of
Cc10+ and Trp63+ cells. To determine the observed plasticity of
AVTII cells in vitro, we isolated type II cells from 4 weeks old non-
doxycycline exposed iSox2SPC-rtTA mice and cultured these
primary cells with or without doxycycline (Figure S4). After three,
six and nine days the cultures were analyzed for the expression of
the myc epitope (iSox2), Cc10, Sca1 and Trp63. The non-
doxycycline treated cells expressed Spc, indicative for AVTII cells,
but obviously lacked expression of Cc10, Sca1 and Trp63
(Figure 7D). However, in cells treated with doxycycline for 3 days
(Figure 7A), 6 days (Figure 7B) and 9 days (Figure 7C), AVTII
cells expressed Sca1, and Cc10, while Trp63 positive cells were
observed only in the cultures exposed to doxycycline for nine days,
which correlated with the in vivo observations (Figure 6D). Taken
together, these data demonstrate that AVTII cells also exhibit
phenotypic plasticity in vitro.
Discussion
The idea that the future potential of differentiated cells is limited
has been gradually adapted, starting with the seminal work of
nuclear replacement in frogs and culminated in the complete
reversal of differentiated fibroblast into multipotent cells by only
four factors [23,53]. These experiments have led to an expansion
of experimental approaches to manipulate and modify cells to give
them multipotent potential [54]. Several adaptations to this
original combination of four factors have been shown to result
in pluripotent cells, depending on the starting source of cells used
as target [55–58]. Recently, in vivo reprogramming has been
show, for instance of resident brain astrocytes in both young adults
and mice with Sox2 only [31].
Our previous study established that ectopic expression of Sox2
during lung development caused cystic lesions and aberrant
differentiation of the epithelial cells [18]. Recently, we showed that
Sox2 directly induced Trp63 and Gata6 expression, which caused
naı¨ve epithelial cells to be become unresponsive to the branch
inducing signal Fgf10 [46]. This led to a skewing of the
developmental potential of the uncommitted cells towards a
proximal cell fate, primarily basal cells. In the current study we
investigated whether Sox2 would be sufficient to redirect the fate
of terminally differentiated alveolar type II cells.
After bleomycin induced injury, type II cells start to proliferate
and repopulate the alveolar epithelium by self-renewal and
functioning as progenitor cells for type I cells [59]. We showed
that induction of Sox2 expression in alveolar type II cells resulted
in the immediate emergence of proliferative cells. Sox2, together
with the Wnt downstream mediator b-catenin, was shown to
directly regulate the promoter of Ccnd1 in breast cancer cells [60],
and we show that the iSox2 positive cells were expressing Pph3
and cyclinD1. Sox17 was also suggested to regulate the Ccnd1
promoter directly, although no ChIP analysis was done [61].
Tompkins et al. added that upon Sox2 expression several other
genes involved in cell cycle initiation and progression were
Figure 7. Primary alveolar type II cells can be reprogrammed in vitro. Representative immunofluorescence images showing expression of
iSox2 (Red), Cc10 (Green), Sca1(Green) and Trp63 (Green) after culturing the primary type II cells with doxycycline for 3 days (A), 6 days (B) and 9 days
(C). AVTII cells cultured for 9 days without doxycycline served as negative controls (D). The results demonstrate that in vitro cultures of AVTII cells
have comparable phenotypic plasticity as AVTII cells in vivo. Scale bar 50 mm (A–C), 100 mm (D).
doi:10.1371/journal.pone.0107248.g007
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upregulated [19]. Within the first week of doxycycline induction,
the iSox2 expressing cells started to express the Sca1 and Ssea1
stem cell markers [51,52]. Moreover, we showed a direct binding
and transactivation of the Sca1 promoter by Sox2, thereby
initiating a progenitor-like program. This suggests that iSox2+/
Sca1+/Ssea1+ cells represent an initial sign of dedifferentiating
type II cells, indicating that Sox2 may initiate alveolar epithelial
cell plasticity by first regulating the emergence of proliferative
intermediate cells, perhaps progenitor-like cells. Thus, our data
suggest a mechanism where Sox2 first induces proliferative
Ssea1+/Sca1+ progenitor cells, which increase over time and
subsequently promote differentiation of these cells into proximal
epithelial cells. Detailed analysis of the progenitor-like, iSox2/
Sca1+/Ssea1+ cells showed a gradual differentiation towards
proximal epithelial cell fate, since these cells started to express
Cc10 and Trp63 after longer exposure to doxycycline, both in vivo
and in vitro. A number of these cells co-expressed Spc and Cc10, a
population also referred to as the bronchioalveolar stem cells
(BASC), which are normally located at the bronchio-alveolar
junctions [49]. These authors also showed that the BASC cells
expressed Sca1, which became proliferative after naphthalene
injury. The cells with characteristics of BASC cells in the iSox2
expressing lungs also expressed Sca1 (Spc+/Cc10+/Sca1+), con-
trasting earlier findings obtained with ectopic Sox17 expression
that did not find these triple positive cells [61]. The Sca1 marker
has been used to purify BASC through fluorescence activated cell
sorting (FACS) using CD452CD312Sca1+ [49,62], but other
studies described this population to be more heterogeneous [63].
BASC cells self-renew and have the potential to differentiate into
proximal and distal epithelial cells [34]. Lineage tracing experi-
ments using a CCSP-CreEr followed by hyperoxia injury
suggested that BASC cells did not give rise to alveolar cells [50],
but after bleomycin injury they did [59]. This would suggest that
BASC cells respond differently to various triggers. Recently,
lineage tracing studies using bleomycin induced lung damage in
Scgb1a1-CreER mice showed that basal cells (Trp63+) in the
damaged parenchyma were directly derived from Clara cells
(Scgb1a1+) [64]. Moreover, upon SO2-induced damage or viral
infection, Clara cells also dedifferentiated into basal cells [65].
Exposure to naphtalene or hyperoxia revealed that Clara cells may
contribute to maintenance and repair of the conducting airways
without dedifferentiating into basal cells [50]. Our current findings
demonstrate that Clara and basal cells may originate from iSox2+/
Sca1+ progenitor cells. However, it remains to be determined
whether these cells are derived from Sca1+ progenitor cells by
genetic lineage tracing experiments.
The continuous proliferation of iSox2 positive cells led to the
emergence of clusters of cells in the alveolar walls with a cuboidal
to columnar appearance, which became apparent after 9 days.
Concomitant with the development of these clusters was the
disruption of the alveolar structure, as evidenced by the
emphysema-like phenotype observed after four weeks of iSox2
expression. The combination of proliferation and the induction of
progenitor-like characteristics resulted in the loss of structural
integrity. The conversion of cell fate combined with the increased
proliferation induced by iSox2 may have changed the secretion
and composition of the extra cellular matrix, which may have
weakened the alveolar structure. This in turn may enhance the
activity of local proteases to digest the tissue matrix and induce
septal rupture, leading to emphysematous-like lungs.
Long term and high ectopic expression of Sox2 in Cc10 positive
cells was shown to result in adenocarcinomas in fifty percent of the
mice [66], but we and others did not find evidence that Sox2
induced lung cancer in our mouse models [19]. The difference in
the various transgenic approaches may contribute to this
discrepancy. However, SOX2 has been associated with human
squamous cell lung tumors (Bass et al, 2009; Hussenet et al, 2010;
Yuan et al, 2010).
The only solution for patients with end-stage, severe chronic
lung disease, like COPD and idiopathic pulmonary fibrosis, is lung
transplantation. However, the shortage of suitable donors may
result in a significant mortality of patients. Therefore, a potential
future treatment for these severe lung diseases is a (temporary)
transplantation with engineered lungs or stem/progenitor cells
[67–69]. However, the approaches for generating these cells have
been limited to the use of combination of factors in vitro
[23,34,70,71]. In addition, a variety of in vitro protocols exist
for differentiating a range of pulmonary epithelial cell types,
including alveolar type II cells [67–69,72–74]. Recently, the direct
conversion of cellular fate has been reported in vivo in a study
demonstrating that neurons can be generated from endogenous
mouse astrocytes that are reprogrammed by viral delivery in situ
[75] In addition, it has been shown that SOX2 is also capable of
converting resident astrocytes into proliferative neuroblasts [31].
We showed that Sox2 alone is sufficient to induce alveolar
plasticity in resident lung alveolar type II cells into progenitors in
adult mice. Our study demonstrates a feasible strategy for using
Sox2 to reprogram alveolar type II cells in vivo and in vitro. In the
future, studies to identify the signaling pathways that regulate the
differentiation of progenitors and the induction of proliferation in
alveolar type II cells will be critical to facilitate the understanding
of alveolar plasticity for future regenerative medicine. Lineage
reprogramming would be applicable in translational medicine if
this event can be triggered by a factor, whether transcription factor
or small molecule, which acts transiently and exerts a complete
effect.
In conclusion, we ectopically expressed one of the Yamanaka
reprogramming factors, Sox2, in type II cells cells using our
previously described system [18,46]. We show that these
dedifferentiate into progenitor-like cells and subsequently commit
to the proximal pulmonary epithelial cell lineages, like basal cells,
extending previous findings with Sox2 and Sox17 [19,61].
Moreover, we show that aside from directly activating the
promoter of the key gene in basal cell development, Trp63 [46],
Sox2 also binds and activates the progenitor cell marker Sca1,
providing molecular evidence for a direct role of Sox2 in the
dedifferentiation process.
Supporting Information
Figure S1 Dual immunofluorescence staining shows the coloca-
lization of the transgenic Sox2 (iSox2, red) with the type II cell
marker Prospc (green) after 6 days (A), 9 days (B) and 28 days (C)
of doxycycline treatment. Scale bars 25 mm.
(TIF)
Figure S2 Colocalization of iSox2 and Phh3 is shown by dual
immunofluorescence labeling after 28 days of doxycycline
exposure. Scale bars 25 mm.
(TIF)
Figure S3 Triple immunofluorescence staining with Myc (iSox2,
blue), Sca1 (green) and Trp63 (red) on lungs of control (A–D) and
iSox2SPC-rtTA (E–H) animals treated for 28 days with doxycycline
demonstrate the emergence of Sca1/Trp63 positive cells (dotted
areas; E–H).
(TIF)
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Figure S4 Immunofluorescence staining with Prospc (A) or
Lpcat1 (B) of isolated type II cells after one day in culture, showing
a high percentage of positive cells after the isolation.
(TIF)
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